Alexander Haragan

Royal Liverpool University Hospital

Dr Alexander Haragan is a pathologist based in Liverpool with a clinical and research interest in thoracic and molecular pathology.

His main clinical and research interests are around targeted therapies for lung cancers, with his work focusing on the tumour immune microenvironment, protein-based biomarkers, genomics and antibody drug congugates as well as the use of digital pathology and AI to improve diagnostics and prediction of response to targeted therapies.

Graduating from the University of Aberdeen with his Medical Degree and first class honours in Biomedical Sciences, Dr Haragan also holds a distinction grade Masters in Pharmacogenomics, a PGCert in Molecular Pathology and has attained his PhD in Immuno-oncology and Clinical Pharmacology.

He sits on the UKNEQAS scientific advisory board and the ESDIP (European society of digital and integrative pathology) scientific committee and is the North England Council Representative for the Royal College of Pathologists. Dr Haragan is an advocate of promoting pathology and improving understanding by working with colleagues and patients in order to deliver the best modern pathology service possible.